Similar findings were observed by several other rodent studies [22,23] and have recently been confirmed in liver biopsies of patients with NAFLD, highlighting the clinical relevance of CD36 in human liver diseases associated with obesity and type 2 diabetes [24]. Here, CD36 is linked to obesity due to melanocortin 4 receptor deficiency.